Hospira Cisplatin 1mg/mL Concentrate for Solution for Infusion 50mg/50mL vial

Active ingredient:

cisplatin, Quantity: 1 mg/mL

Available from:

Hospira Australia Pty Ltd

INN (International Name):

Cisplatin

Pharmaceutical form:

Injection, intravenous infusion

Composition:

Excipient Ingredients: mannitol; sodium chloride; water for injections; hydrochloric acid; sodium hydroxide

Administration route:

Intravenous Infusion

Units in package:

1x 50mL pack

Class:

Medicine Listed (Export Only)

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Cisplatin is used in the treatment of certain types of cancer, for example ovarian cancer, testicular cancer, bladder cancer and head and neck cancer. Cisplatin may be used in combination with other anti-cancer medicines.

Product summary:

Visual Identification: A clear, colourless to pale yellow solution, free from visible particulates.; Container Type: Vial; Container Material: Glass Type I Coloured; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Authorization status:

Listed (Export Only)

Authorization date:

2009-02-11